Johnson & Johnson
Khaled Sarsour is an accomplished leader in data science and real-world evidence, currently serving as Vice President at The Janssen Pharmaceutical Companies of Johnson & Johnson since July 2021, where oversight includes a multidisciplinary team of data scientists and responsibilities for RWE methods across therapeutic areas. Concurrently, Khaled Sarsour acts as a Visiting Senior Lecturer at King's College London, educating students in health care data science and pharmacoepidemiology. Previous experience includes significant roles at Genentech, where leadership spanned global real-world data initiatives in oncology and hematology, and Eli Lilly and Company, focusing on health outcomes research for neurodegenerative diseases. Academic qualifications include a PhD in Social Epidemiology, an MPH in Epidemiology and Biostatistics, and an AB in Molecular Biology and Biochemistry, all obtained from the University of California, Berkeley.
This person is not in any offices
Johnson & Johnson
541 followers
Johnson & Johnson and its subsidiaries have approximately 141,700 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the healthcare field. Johnson & Johnson is a holding company, with operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. Johnson & Johnson is organized into three business segments: Consumer Health, Pharmaceutical and Medical Devices. The Consumer Health segment includes a broad range of products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology (e.g., rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease and psoriasis), Infectious Diseases (e.g., HIV/AIDS and COVID-19), Neuroscience (e.g., mood disorders, neurodegenerative disorders and schizophrenia), Oncology (e.g., prostate cancer, hematologic malignancies, lung cancer and bladder cancer), Cardiovascular and Metabolism (e.g., thrombosis, diabetes and macular degeneration) and Pulmonary Hypertension (e.g., Pulmonary Arterial Hypertension). Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals and healthcare professionals for prescription use. The Medical Devices segment includes a broad range of products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields. At Johnson & Johnson, employees are guided by Our Credo which sets forth the Company’s responsibilities to patients, consumers, customers, healthcare professionals, employees, communities and shareholders. The Company is committed to workplace diversity and to cultivating, fostering, and advancing a culture of equity and inclusion. Enabling employees to perform at their best while being themselves is fundamental to the Company’s continued success. The Company’s DEI vision is: Be yourself, change the world.